Novo Holdings Acquires 25% Stake in Sejet Plant Breeding

Novo Holdings Leads €7M Seed Investment in Bactolife

April 20, 2021

Biotechnology

Novo Holdings (via its Novo Seeds team) led a €7 million seed round in Danish biotech Bactolife, committing €5 million to advance the company's pipeline. The funding will support development and scaling of Bactolife's anti-virulence Virulence Inactivating Proteins (VIPs) for animal and human gut health; Novo's Aleks Engel will join Bactolife's board.

Novo Holdings Leads $50M Growth Investment in MedGenome

August 30, 2022

Biotechnology

Novo Holdings led a $50 million minority investment in MedGenome alongside existing investors LeapFrog Investments and Sofina. The capital will support MedGenome’s expansion beyond South Asia into Africa and the Middle East and broaden access to its genomic testing, bioinformatics and research services.

Novo Holdings Invests in AgNext Technologies

June 25, 2024

Agriculture

Novo Holdings led a growth investment in AgNext Technologies Private Limited, an India-based agritech company that develops AI-driven food quality assessment solutions. The funding will support product development, international expansion and scaling of sales to new food segments.

Novo Holdings Invests $72 Million in LanzaTech

August 6, 2019

Biotechnology

Novo Holdings A/S made a $72 million Series E growth equity investment in LanzaTech to support expansion and commercialization of the company's carbon-recycling fuels and chemicals platform. Anders Bendsen Spohr of Novo Holdings will join LanzaTech's board as the investment aims to accelerate deployment of LanzaTech's sustainable fuels, chemicals and polyethylene produced from recycled carbon.

Novo Holdings Acquires Majority Stake in Stingray Marine Solutions

October 10, 2024

Agriculture

Novo Holdings has agreed to acquire a majority stake in Stingray Marine Solutions, an Oslo-based provider of intelligent aquaculture technology that removes sea lice using camera vision, software and laser technology. The investment, made by Novo Holdings’ Planetary Health Investments team, is intended to scale Stingray’s sustainable aquaculture solutions and expand opportunities in data & analytics and precision farming.

Novo Holdings Invests $40M in Evosep

January 9, 2023

Biotechnology

Novo Holdings has invested $40 million in Evosep to accelerate the commercialization and clinical application of Evosep’s standardized proteomics liquid chromatography platform. The funds will support product development and global expansion — particularly into the U.S. — and Novo Holdings’ principal, Stephen Van Helden, will join Evosep’s board.